St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 108   

Articles published

STJ 73.84 -0.07 (-0.09%)
price chart
St. Jude Medical to Buy Thoratec for $3.4 Billion
St. Jude is aiming to expand its portfolio of devices for the treatment of heart failure, a condition affecting some six million people in the U.S.
St. Jude Medical buying Thoratec for $3.4 billion in move to expand heart ...  Vancouver Sun
St. Jude Medical Said in Talks to Buy Implant Maker Thoratec  Bloomberg
BMO Capital Downgrades St. Jude Medical On 'Less Compelling' Risk/Reward
In a report published Thursday, BMO Capital Markets analyst Joanne Wuensch downgraded the rating on St. Jude Medical, Inc. (NYSE: STJ) from Outperform to Market Perform, while raising the price target from $80 to $81. St. Jude reported its 2Q15 results ...
Shares of St. Jude Medical, Inc. (NYSE:STJ) Sees Large Outflow of Money  Money Flow Index
St. Jude Medical (STJ) Stock Downgraded at Deutsche Bank, BMO Capital
What after Daniel Starks's Insider Sale of St. Jude Medical, Inc. (NYSE:STJ ...
St. Jude Medical, Inc. (NYSE:STJ) 73.84 -0.07 -0.09% Chairman - CEO & President Daniel Starks on the 31/07/2015 unloaded a total of 100,000 shares of the Minnesota-based company valued by the market at approximately $7,393,000 U.S.
St Jude Medical Inc (STJ) Files Form 4 Insider Selling : Daniel J Starks ...  Insider Trading Report
Zacks Rating on St. Jude Medical, Inc.
St. Jude Medical, Inc. (NYSE:STJ): The mean short term price target for St. Jude Medical, Inc. (NYSE:STJ) has been established at $81.53 per share. The higher price target estimate is at $91 and the lower price target estimate is expected at $64 ...
St. Jude Medical Receives FDA Approval for the Industry's First Spinal Cord ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA approval of the St. Jude Medical™ Invisible Trial System.
St. Jude Medical's Invisible Trial System Gets FDA Approval - Analyst Blog  Nasdaq
St. Jude Medical Given "AA-" Credit Rating by Morningstar (STJ)
St. Jude Medical logo St. Jude Medical (NYSE:STJ) has received an “AA-” credit rating from analysts at Morningstar.
Large Outflow of Money Witnessed in St. Jude Medical, Inc.
St. Jude Medical, Inc. (NYSE:STJ) traded higher in the last at $74.22, gaining 0.28 points or 0.38%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-2.06 ...
St. Jude Medical, Inc. (NYSE:STJ) Short Interest Update  Insider Trading Report
Analysts Take on St. Jude Medical, Inc. (NYSE:STJ)  Markets Daily
Thoratec Could Fetch $65-$70 In Buyout, Predicts Northland's Suraj Kalia
In a report published Wednesday, Northland Capital Markets analyst Suraj Kalia maintained an Outperform rating on Thoratec Corporation (NASDAQ: THOR), with a price target of $55, amid speculations of the company being acquired by St. Jude Medical, ...
New Lifetime High Reached By St Jude Medical (STJ)
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.
Short Interest Update of St. Jude Medical, Inc. (NYSE:STJ)  Money Flow Index
Ratings Watch: St. Jude Medical, Inc. (NYSE:STJ)
Shares of St. Jude Medical, Inc. (NYSE:STJ) have been given a consensus rating of 1.69 by brokerage analysts covering the stock.